A study comparing two ways to monitor anasthesia to see which helps patients wake up faster from anasthesia in patients undergoing elective breast surgeries in a tertiary cancer care hospital

A prospective randomized comparative study of recovery time by using bispectral index versus end tidal agent concentrate monitoring in patients undergoing elective breast surgeries in a tertiary cancer care hospital - NIL

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/07/091918

Enrollment

Registered

2025-07-28

Start date

Unknown

Completion date

Unknown

Last updated

2025-08-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: C509- Malignant neoplasm of breast of unspecified site Health Condition 2: C501- Malignant neoplasm of central portion of breast Health Condition 3: O- Medical and Surgical

Interventions

Intervention1: ANAESTHETIC AGENT DESFLURANE: NIL Control Intervention1: NIL: NIL Control Intervention2: BISPECTRAL INDEX VERSUS END TIDAL ANAESTHETIC AGENT: NA

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients undergoing elective breast surgery 2. Patients aged more than 18 years 3. American Society of Anaesthesiology (ASA) physical status 1 and 2 4. Provised consent to procedure

Exclusion criteria

Exclusion criteria: 1. Patients with history of long term used of anti-convulsants, opiates, benzodiazepines, cocaine, alcohol 2. Patients with pre-existing renal, hepatic, cardiac disease and dementia

Design outcomes

Primary

Measure	Time frame
To assess extubation time and recovery time using bispectral index and end tidal anaesthetic agentTimepoint: 2-3hours	—

Secondary

Measure	Time frame
total consumption of desflurane, hemodynamic stability of the patients and discharge from post-anaesthetic care unitTimepoint: 1-2hours	—

Countries

India

Contacts

Public ContactDR BABY LALMALSAWMI

KIDWAI MEMORIAL INSTITUTE OF ONCOLOGY

drhenjarappa@gmail.com9448933654

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026